Cardiometabolic disease is a composite term encompassing a constellation of health conditions that collectively heighten the risk of both cardiovascular disease and metabolic disorders, presenting a formidable health challenge in contemporary society. This intricate cluster includes maladies such as dyslipidemia, insulin resistance, and abdominal obesity, all of which synergistically contribute to an increased susceptibility to heart disease and related complications. The complex interplay of genetic factors, environmental influences, and individual behaviors underscores the multifactorial nature of cardiometabolic diseases. Unhealthy dietary patterns, sedentary lifestyles, and a genetic predisposition can collectively propel the onset and progression of these interconnected conditions. Timely identification and the implementation of comprehensive management approaches are paramount in curbing the impact of cardiometabolic diseases. Emphasis on lifestyle modifications, medication adherence, and routine health assessments becomes imperative in fostering improved outcomes. Public health campaigns dedicated to awareness, education, and preventive interventions emerge as key components in tackling the growing prevalence of cardiometabolic disease and fostering a healthier and more resilient population.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation